Chembio Diagnostics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Chembio Diagnostics generated cash of -$12,693,953, which is more than the previous year. Cash used in financing activities reached the amount of $3,367,253 last year. Net change in cash is therefore -$10,593,907.
Cash Flow
| 2013 | 2.27M | -885.60K | 5.30M |
|---|---|---|---|
| 2014 | -3.82M | -1.45M | 237.16K |
| 2015 | 1.79M | -1.03M | -700K |
| 2016 | -6.70M | -668.70K | 12.55M |
| 2017 | -5.03M | -1.87M | 134.28K |
| 2018 | -11.78M | -6.95M | 27.48M |
| 2019 | -9.05M | -3.75M | 18.49M |
| 2020 | -18.88M | -4.16M | 27.76M |
| 2021 | -30.88M | -1.85M | 38.69M |
| 2022 | -12.69M | -1.45M | 3.36M |
CEMI Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 28.77M | 23.06M | 18.27M | 12.52M | 3.79M | 10.55M | 5.37M | 4.61M | 9.65M | 2.95M |
Operating activities | ||||||||||
Net income | -23.29M | -33.90M | -25.52M | -13.67M | -7.86M | -6.37M | -13.34M | -2.39M | -1.13M | 530.81K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.55M | 2.93M | 2.69M | 1.91M | 902.50K | 1.27M | 1.13M | 1.37M | 739.29K | 607.82K |
Stock-based compensation expense | 2.29M | 2.43M | 1.22M | 1.65M | 632.80K | 384.89K | 304.15K | 334.38K | 447.1K | 331.87K |
| Deferred income tax benefit | 2.29M | 2.43M | 1.22M | 1.65M | 632.80K | 384.89K | 304.15K | 334.38K | 447.1K | 331.87K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 4.80M | -8.00M | 283.93K | 3.76M | -5.15M | 1.29M | -960.75K | 5.91M | -3.77M | 263.23K |
Inventories | 4.63M | -4.45M | -6.46M | -1.45M | -3.07M | -1.08M | 242.83K | 60.27K | -449.57K | -700.65K |
Accounts payable | 0 | 1.91M | 3.99M | -467.28K | 2.48M | -44.05K | 76.92K | -2.33M | 390.22K | 843.59K |
Cash generated by operating activities | -12.69M | -30.88M | -18.88M | -9.05M | -11.78M | -5.03M | -6.70M | 1.79M | -3.82M | 2.27M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.45M | -1.85M | -4.16M | -3.79M | -1.46M | -1.02M | -118.70K | -1.03M | -1.45M | -885.60K |
Acquisitions Net | 0 | 0 | 0 | 45.76K | -5.49M | -850K | -550K | 0 | 0 | 0 |
Cash generated by investing activities | -1.45M | -1.85M | -4.16M | -3.75M | -6.95M | -1.87M | -668.70K | -1.03M | -1.45M | -885.60K |
Financing activities | ||||||||||
Common Stock Issued | 4.31M | 38.81M | 28.43M | 0 | 27.47M | 0 | 12.49M | 0 | 0 | 5.40M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -61.86K | -3.20M | 0 | -64.48K | 0 | 0 | 0 | 0 | -133.48K |
Cash used in financing activities | 3.36M | 38.69M | 27.76M | 18.49M | 27.48M | 134.28K | 12.55M | -700K | 237.16K | 5.30M |
Net Change In Cash | -10.59M | 5.70M | 4.79M | 5.74M | 8.73M | -6.76M | 5.17M | 762.39K | -5.03M | 6.69M |
Cash at end of period | 18.17M | 28.77M | 23.06M | 18.27M | 12.52M | 3.79M | 10.55M | 5.37M | 4.61M | 9.65M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |